Q2 EPS Estimates for Core Scientific Reduced by Roth Capital

Core Scientific, Inc. (NASDAQ:CORZ - Free Report) - Analysts at Roth Capital dropped their Q2 2026 EPS estimates for Core Scientific in a report issued on Wednesday, April 9th. Roth Capital analyst D. Aftahi now forecasts that the company will post earnings per share of $0.02 for the quarter, down from their prior estimate of $0.04. The consensus estimate for Core Scientific's current full-year earnings is $0.52 per share. Roth Capital also issued estimates for Core Scientific's Q3 2026 earnings at $0.02 EPS, Q4 2026 earnings at $0.05 EPS, FY2026 earnings at $0.07 EPS and FY2028 earnings at $0.94 EPS.

Core Scientific (NASDAQ:CORZ - Get Free Report) last issued its quarterly earnings data on Wednesday, February 26th. The company reported ($0.01) earnings per share for the quarter, topping analysts' consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to analysts' expectations of $97.07 million.

Several other brokerages have also commented on CORZ. Compass Point decreased their price objective on Core Scientific from $26.00 to $20.00 and set a "buy" rating for the company in a report on Tuesday, February 25th. Craig Hallum started coverage on Core Scientific in a research note on Tuesday, January 21st. They issued a "buy" rating and a $24.00 price target for the company. Needham & Company LLC dropped their price target on Core Scientific from $18.00 to $17.00 and set a "buy" rating on the stock in a research note on Thursday, February 27th. Keefe, Bruyette & Woods assumed coverage on shares of Core Scientific in a report on Monday, January 27th. They set an "outperform" rating and a $22.00 price objective on the stock. Finally, Canaccord Genuity Group reiterated a "buy" rating and issued a $17.00 target price on shares of Core Scientific in a research note on Wednesday, March 12th. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Buy" and a consensus target price of $19.07.

Remove Ads

Core Scientific Stock Down 3.0 %

Shares of Core Scientific stock traded down $0.21 on Friday, reaching $6.85. The stock had a trading volume of 9,965,036 shares, compared to its average volume of 12,349,991. Core Scientific has a 1 year low of $2.61 and a 1 year high of $18.63. The company has a 50 day moving average price of $9.28 and a 200 day moving average price of $12.69. The stock has a market capitalization of $2.02 billion, a P/E ratio of -1.27 and a beta of 6.80.

Institutional Investors Weigh In On Core Scientific

Several large investors have recently bought and sold shares of the company. Wellington Shields & Co. LLC acquired a new position in Core Scientific in the 4th quarter valued at $26,000. First Horizon Advisors Inc. acquired a new position in Core Scientific during the fourth quarter worth about $34,000. Newbridge Financial Services Group Inc. purchased a new stake in Core Scientific during the 4th quarter valued at about $42,000. GAMMA Investing LLC raised its holdings in Core Scientific by 1,722.3% in the 1st quarter. GAMMA Investing LLC now owns 8,565 shares of the company's stock valued at $62,000 after acquiring an additional 8,095 shares during the last quarter. Finally, Vestcor Inc purchased a new position in Core Scientific in the 4th quarter worth approximately $66,000.

Insider Transactions at Core Scientific

In other Core Scientific news, Director Jordan Levy bought 62,500 shares of Core Scientific stock in a transaction dated Thursday, March 6th. The stock was acquired at an average cost of $8.01 per share, with a total value of $500,625.00. Following the purchase, the director now directly owns 306,887 shares in the company, valued at $2,458,164.87. This represents a 25.57 % increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Todd M. Duchene sold 25,277 shares of the business's stock in a transaction on Friday, January 24th. The stock was sold at an average price of $16.24, for a total transaction of $410,498.48. Following the completion of the sale, the insider now directly owns 2,023,423 shares of the company's stock, valued at approximately $32,860,389.52. The trade was a 1.23 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 530,041 shares of company stock valued at $7,870,352 in the last 90 days. 32.00% of the stock is currently owned by company insiders.

About Core Scientific

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.